Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

IMMXIMMX
7 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in IMMIX BIOPHARMA INC

CITADEL ADVISORS LLC holds 506,157 shares of IMMX (IMMIX BIOPHARMA INC), worth $5.2M as of 2026-Q2. The position was increased (+973.0% shares). IMMX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$5.2M

Current Shares

506,157

Total Value Change

+$5.1M

Total Shares Change

+479,683

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
506,157
+973.0%
$5.2M0.0%$10.31
44
2026-Q1
Decreased
47,173
-37.4%
$429,7460.0%$8.15
0
2025-Q4
Decreased
75,338
-16.1%
$394,0180.0%$5.28
0
2025-Q3
New
89,798
-
$187,6770.0%$2.08
35
2022-Q2
Exited
0
-100.0%
$00.0%$2.52
0
2022-Q1
Decreased
21,713
-18.0%
$52,0000.0%$2.35
0
2021-Q4
New
26,474
-
$94,0000.0%$3.26
33

Other major holders of IMMX: Janus Henderson Group Ltd., STATE STREET CORP, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used